Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 2

1.

Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty.

Palmert MR, Mansfield MJ, Crowley WF Jr, Crigler JF Jr, Crawford JD, Boepple PA.

J Clin Endocrinol Metab. 1999 Dec;84(12):4480-8.

PMID:
10599706
[PubMed - indexed for MEDLINE]
2.

Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.

Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF Jr, Crawford JD, Crowley WF Jr.

Endocr Rev. 1986 Feb;7(1):24-33. Review.

PMID:
2937629
[PubMed - indexed for MEDLINE]

Supplemental Content

Write to the Help Desk